
Bern, Switzerland - A study published in July’s Archives of Dermatology suggests that patients with moderate to severe plaque psoriasis may develop papular eruptions during efalizumab treatment - and that because these are new psoriatic lesions, the condition could be referred to as efalizumab-associated papular psoriasis or EAPP, according to a HealthDay News report.
